A Plus Biotechnology CoTPE:6918 -1.59%71 Dividend Yield % is 6.73% as of Jul. 08, 2026, which is 141% above its 10-year median of 2.79. GuruFocus rates TPE:6918 with a GF Score™ of 71/100 and a GF Value™ of NT$87.15 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 327 Medical Devices & Instruments companies, A Plus Biotechnology Co ranks better than 95.41% on this metric.
As of today (2026-07-08), the Trailing Annual Dividend Yield of A Plus Biotechnology Co is 6.73%.
Good Sign:
A Plus Biotechnology Co Ltd stock Dividend Yield % is close to 3-year high.
The historical rank and industry rank for A Plus Biotechnology Co's Dividend Yield % or its related term are showing as below:
TPE:6918'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.78 Med: 2.79 Max: 7.53
Current: 6.73
During the past 7 years, the highest Dividend Yield of A Plus Biotechnology Co was 7.53%. The lowest was 0.78%. And the median was 2.79%.
TPE:6918's Dividend Yield % is ranked better than 95.41% of 327
companies
in the Medical Devices & Instruments industry
Industry Median: 1.91
vs TPE:6918: 6.73
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of A Plus Biotechnology Co Ltd is 0.78, which seems too high.
During the past 7 years, the highest Dividend Payout Ratio of A Plus Biotechnology Co was 0.78. The lowest was 0.55. And the median was 0.66.
During the past 12 months, A Plus Biotechnology Co's average Dividends Per Share Growth Rate was 46.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
A Plus Biotechnology Co (TPE:6918) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6918 vs ABT, SYK, MDT: Dividend Yield % Comparison
For the Medical Devices subindustry, A Plus Biotechnology Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
A Plus Biotechnology Co Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, A Plus Biotechnology Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where A Plus Biotechnology Co's Dividend Yield % falls into.
A Plus Biotechnology Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
A Plus Biotechnology Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 5.000000
2026-03-27
2026-03-30
2026-04-27
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A Plus Biotechnology Co (TPE:6918) has a Dividend Yield % of 6.73% as of Jul. 08, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on A Plus Biotechnology Co and its competitors. This is 141% above median its historical median of 2.79. Over the past decade, A Plus Biotechnology Co's Dividend Yield % has ranged from 0.78 to 7.53. According to the industry distribution chart, A Plus Biotechnology Co ranks #15 out of 327 companies in the Medical Devices & Instruments industry, placing it in the top 4.6%.
Is A Plus Biotechnology Co's Dividend Yield % too high?
A Plus Biotechnology Co's current Dividend Yield % of 6.73% is 141% above median its 10-year median of 2.79. Over the past 10 years, this metric has ranged from a low of 0.78 to a high of 7.53. The Medical Devices & Instruments industry median Dividend Yield % is 1.91. A Plus Biotechnology Co's value of 6.73% is 252.4% above this industry median. Based on the distribution chart, A Plus Biotechnology Co ranks #15 out of 327 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, A Plus Biotechnology Co has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does A Plus Biotechnology Co's Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, A Plus Biotechnology Co ranks #15 out of 327 companies for Dividend Yield %. This places A Plus Biotechnology Co in the top 5% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.91. A Plus Biotechnology Co's value of 6.73% is 252.4% above this benchmark. Historically, A Plus Biotechnology Co's own Dividend Yield % has ranged from 0.78 to 7.53 over the past decade. While the company's 10-year median is 2.79 vs. the industry median of 1.91, A Plus Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.91, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. A Plus Biotechnology Co's current Dividend Yield % of 6.73% is 252.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on A Plus Biotechnology Co and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. A Plus Biotechnology Co's current Dividend Yield % is 6.73%, which is 141% above median its own 10-year median of 2.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is A Plus Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, A Plus Biotechnology Co (TPE:6918) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.15, compared to a current price of NT$74.30 — trading 14.7% below its estimated fair value. The current Dividend Yield % is 6.73%, which is 141% above median its 10-year median of 2.79 and 252.4% above the Medical Devices & Instruments industry median of 1.91. A Plus Biotechnology Co's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For A Plus Biotechnology Co (TPE:6918), the current Dividend Yield % is 6.73% as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is A Plus Biotechnology Co (TPE:6918) Overvalued in 2026?
Based on GuruFocus' analysis, A Plus Biotechnology Co stock appears to be undervalued.
The current stock price of NT$74.30 is trading 14.7% below its estimated GF Value™ of NT$87.15.
GuruFocus considers A Plus Biotechnology Co to be Modestly Undervalued.
Key valuation signals for TPE:6918:
Dividend Yield %: 6.73% (141% above median its 10-year median of 2.79)
GF Value™: NT$87.15 vs. price of NT$74.30 (14.7% below fair value)
Industry Position: 252.4% above the Medical Devices & Instruments median (#15 of 327)
No single metric tells the full story. See the TPE:6918 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
A Plus Biotechnology Co Ltd provides orthopedic implants and engages in the manufacturing and wholesale of medical devices such as bone material. The company's products include Chest, Shoulder, Spine, Elbow, Wrist & Hand, Pelvic & Hip, Knee, Foot & Ankle, Osteotomy, Pediatric & ESF, and Biologics. The company currently has operating segments in Taiwan and China, with the majority of revenue coming from Taiwan.
71GF Score
Get the complete analysis for TPE:6918
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6918 has been successfully added to your 
